U.S. Markets close in 2 hrs 31 mins

LeMaitre Vascular, Inc. (LMAT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
44.80+1.27 (+2.92%)
As of 04:00PM EDT. Market open.

LeMaitre Vascular, Inc.

63 Second Avenue
Burlington, MA 01803
United States
781 221 2266

IndustryMedical Instruments & Supplies
Full Time Employees450

Key Executives

NameTitlePayExercisedYear Born
Mr. George W. LeMaitreChairman & CEO882.03k2.27M1965
Mr. David B. RobertsPres & Director603.01k753.92k1964
Mr. Joseph P. Pellegrino Jr.CFO, Treasurer, Sec. & Director518.6k30.04k1965
Mr. Trent G. KamkeSr. VP of Operations368.62k921.27k1971
Dr. George D. LeMaitreFounder and Chairman of Scientific Advisory BoardN/AN/A1934
Ms. Laurie A. ChurchillSr. VP & Gen. CounselN/AN/A1971
Ms. Kimberly L. CieslakVP of MarketingN/AN/A1973
Mr. Daniel J. MumfordDirector of HRN/AN/A1982
Mr. Andrew HodgkinsonSr. VP of Clinical, Regulatory & Quality AffairsN/AN/A1976
Mr. Stephane MaierSr. VP of EMEA OperationsN/AN/A1976
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Corporate Governance

LeMaitre Vascular, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 8. The pillar scores are Audit: 9; Board: 9; Shareholder Rights: 7; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.